Genetics
By Chris MorrisJune 16, 2025
HealthDozens of states sue to block the sale of 23andMe’s genetic data after its former CEO pushes the purchase price $50 million higher
By Marco Quiroz-GutierrezJune 12, 2025
ConferencesJamie Dimon says AI will mean people live to 100: It’s possible, says genetic testing CEO, but relies on these three factors
By Eleanor PringleMay 6, 2025
NewslettersAt a family reunion she discovered multiple relatives had cystic fibrosis. Decades later she’s built a $2.6 billion genetic testing company
By Emma Hinchliffe and Nina AjemianApril 8, 2025
TechAs a kid, she raised money to cure cystic fibrosis. Now she’s the CEO of a $2.6 billion genetic testing company
By Andrew NuscaMarch 31, 2025
By Alexa Mikhail and Beth GreenfieldMarch 24, 2025
LifeThis company is launching a genetic matching feature for future parents—and the CEO says ‘it has nothing to do with eugenics’
By Alexa MikhailMarch 23, 2025
By Lindsey LeakeFebruary 6, 2025
By Lauran Neergaard and The Associated PressFebruary 5, 2025
By Lindsey LeakeFebruary 3, 2025
HealthPharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
By Lindsey LeakeJanuary 16, 2025
HealthMerck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
By Lindsey LeakeDecember 20, 2024
TechAfter its entire board resigned overnight, 23andMe will cut over 200 employees and its cancer research in an urgent bid to nurse the company back to health
By Sasha RogelbergNovember 12, 2024
